DelveInsight’s “Cytomegalovirus (CMV) Infection - Epidemiology Insights-2023-Japan” Report provides an overview of the disease and the historical and forecasted epidemiological data of the Cytomegalovirus (CMV) Infection in Japan for 2013-2023. The report considers the transplant patients, HIV patients and Infants under high risk for CMV infections and epidemiology forecast for these high risk categories have also been taken into consideration.
According to DelveInsight, the total number of Diagnosed Cytomegalovirus (CMV) Infection cases is expected to increase at a CAGR of 0.056% to7,355 cases in 2023. Out of all these high risk categories, Infants have comparatively higher number of CMV prevalent cases than HIV and Transplant patients in Japan.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis and disease management.
• Identifying patient populations in the Japan Cytomegalovirus (CMV) Infection market
• The Report covers the historical and forecasted epidemiological data covering Japan from 2013-2023.
'
Disease Overview
Symptoms of cytomegalovirus (CMV) Infection
Etiology
Risk Factors
Pathogenesis of human cytomegalovirus
Pathophysiology of cytomegalovirus infection
Diagnosis
Epidemiology and Patient Population
Japan
Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data(2013-2015)
Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data(2016-2023)
CMV Patients among Transplants: Historical Data(2013-2015)
CMV Patients among Transplants: Forecasted Data(2016-2023)
Infant Patients at High Risk of CMV: Historical Data(2013-2015)
Infant Patients at High Risk of CMV: Forecasted Data(2016-2023)
HIV Patients at High Risk of CMV : Historical Data(2013-2015)
HIV Patients at High Risk of CMV : Forecasted Data(2016-2023)
Unmet Medical Needs
Assumptions and Rationale
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Table 1: Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data(2013-2015)
Table 2: Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data(2017-2023)
Table 3: CMV Patients among Transplants: Historical Data(2013-2015)
Table 4: CMV Patients among Transplants: Forecasted Data(2017-2023)
Table 5: Infant Patients at High Risk of CMV: Historical Data(2013-2015)
Table 6: Infant Patients at High Risk of CMV: Forecasted Data(2017-2023)
Table 7: HIV Patients at High Risk of CMV : Historical Data(2013-2015)
Table 8: HIV Patients at High Risk of CMV : Forecasted Data(2017-2023)
